Managed Care Marketing

This section includes useful information to help Medicare Advantage Plans, Medicare Advantage Prescription Drug Plans, Prescription Drug Plans, and 1876 Cost Plans with Marketing efforts.

CY 2013 Model Material Release

CMS is pleased to announce the release of several important Contract Year (CY) 2013 model marketing materials; specifically, the standardized Annual Notice of Change (ANOC) and Evidence of Coverage (EOC) templates, ANOC/EOC Errata, and Provider Directory. All models and any applicable instructions are included below.  Please click on the link titled CY 2013 Model Marketing Materialslocated in the Downloads section.

Issuance of the Final Contract Year (CY) 2013 Medicare Marketing Guidelines (MMG)

CMS is pleased to announce the release of the CY 2013 MMG. This year, we conducted a comprehensive review of the MMG with a focus on streamlining, consolidating, and removing outdated requirements.  We released the draft MMG for public comment on February 16, 2012, and received approximately 1,775 comments.  These came from 106 entities, including MAOs, PDP sponsors, consumer advocacy groups, pharmacy associations, health plan associations, and State departments of health.  After careful analysis of all comments received, we have made a number of important revisions and clarifications to the final guidance.

CMS-State Collaboration Activities

The Centers for Medicare & Medicaid Services (CMS) as a part of our agreement to share information and collaborate on oversight issues with the State Departments of Insurance (DOIs), has strengthened protections for particularly vulnerable beneficiaries. CMS and participating State DOIs have signed a joint letter to educate and protect residents of low income senior and Independent Care for the Mentally Retarded and the Mentally Retarded and Developmentally Disabled (ICF/MR) housing facilities concerning inappropriate behavior of agents. In this letter, we urge facility administrators to be vigilant in reporting suspect Medicare Advantage and Prescription Drug plan marketing. We also describe Medicare and Medicaid patient rights and protections relative to agent behaviors as afforded under MIPPA. CMS continues to work collaboratively with the States where the sharing of information will not only strengthen State and Federal oversight efforts, but provide more protection for Medicare beneficiaries.